Goldman Sachs analyst Neil Mehta boosted their SLB price target to $49 from $43, partly due to the potential for revenue in ...
Two persons have died after an outbreak of Guillain-Barré Syndrome, an immunological nerve disorder, in Madhya Pradesh’s ...